These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 7726968

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjunctive use of hydroxychloroquine in childhood dermatomyositis.
    Olson NY, Lindsley CB.
    J Rheumatol; 1989 Dec; 16(12):1545-7. PubMed ID: 2483176
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
    Boogaard R, Drexhage VR, van Suijlekom-Smit LW.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):146-50. PubMed ID: 15693592
    [Abstract] [Full Text] [Related]

  • 5. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
    Arnson Y, Dovrish Z, Hadari R, Amital H.
    Isr Med Assoc J; 2007 Jun 15; 9(6):492-3. PubMed ID: 17642406
    [No Abstract] [Full Text] [Related]

  • 6. Amyopathic dermatomyositis, photosensitivity and hydroxychloroquine.
    Cox NH.
    Br J Dermatol; 1995 Jun 15; 132(6):1016-7. PubMed ID: 7662554
    [No Abstract] [Full Text] [Related]

  • 7. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS, Costner MI.
    J Am Acad Dermatol; 2008 Mar 15; 58(3):403-6. PubMed ID: 18194823
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Simvastatin-induced amyopathic dermatomyositis.
    Inhoff O, Peitsch WK, Paredes BE, Goerdt S, Goebeler M.
    Br J Dermatol; 2009 Jul 15; 161(1):206-8. PubMed ID: 19438466
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A case series of hydroxychloroquine exacerbating the dermatomyositis rash.
    Rypka K, Buonomo M, Buechler C, Benolken M, Swigost A, Konstantinov N, Gaddis K, Goldfarb N.
    Dermatol Online J; 2023 Oct 15; 29(5):. PubMed ID: 38478643
    [Abstract] [Full Text] [Related]

  • 13. Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous Dermatomyositis.
    Kurtzman DJ, Ho A, Wright NA, Rubenstein MH, Vleugels RA.
    JAMA Dermatol; 2016 Sep 01; 152(9):1062-3. PubMed ID: 27275922
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Controversies in juvenile dermatomyositis.
    Malleson PN.
    J Rheumatol Suppl; 1990 Jun 01; 23():1-2; discussion 3-6. PubMed ID: 2376863
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
    King LE, Park JH, Adams LB, Olsen NJ.
    Arch Dermatol; 1995 May 01; 131(5):522-4. PubMed ID: 7741537
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Juvenile dermatomyositis and overlap syndromes.
    Paller AS.
    Adv Dermatol; 1995 May 01; 10():309-26; discussion 327. PubMed ID: 7794676
    [No Abstract] [Full Text] [Related]

  • 20. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA, de Haas PW, Visscher F, Sabbe LJ, Busch HF, van Doorn PA.
    Ned Tijdschr Geneeskd; 1993 Sep 25; 137(39):1979-82. PubMed ID: 8413708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.